20
Divis Laboratories Ltd, based in India, is a pharmaceutical company that stands out with its certifications from FDA, EDQM and WHO-GMP.
One of their notable products is MESALAMINE USP, with a corresponding US DMF Number 29998.
Remarkably, this DMF maintains an Active status since its submission on November 06, 2015, highlighting commitment to regulatory compliance.
Their GDUFA DMF Review was successfully complete, with a review date of April 08, 2016, and payment made on December 02, 2015, indicating their dedication to facilitating drug approvals, Categorized as Type II